Biogen beats reduced EPS estimates

BGEN reported second quarter operating earnings of $0.39, $0.03 above the Street's consensus and a penny above the high end of BGEN's recently reduced guidance. BGEN's second quarter EPS figure was 26%

Read the full 324 word article

How to gain access

Continue reading with a
two-week free trial.